You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Profile for Japan Patent: 2015517382


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 2015517382

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Sep 30, 2031 The Medicines Co IONSYS fentanyl hydrochloride
⤷  Get Started Free May 21, 2032 The Medicines Co IONSYS fentanyl hydrochloride
⤷  Get Started Free Jun 11, 2032 The Medicines Co IONSYS fentanyl hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of Patent JP2015517382: Scope, Claims, and Patent Landscape

Last updated: August 8, 2025


Introduction

Patent JP2015517382, filed in Japan, pertains to a pharmaceutical invention—specifically, a novel chemical entity or formulation designed for therapeutic application. As an integral element within the Japanese patent landscape, this patent's scope and claims offer insights into technological advancements, competitive positioning, and strategic patenting approaches within the pharmaceutical sector. This analysis dissects the patent’s claims, scope, and its interactions within the broader patent landscape.


Patent Overview

Publication Number: JP2015517382
Filing Date: It is necessary to verify the initial filing date from patent databases. (Assuming 2015 based on the publication number, which indicates publication in 2015).
Priority Data: Typically, Japanese patents double as national entries, often claiming priority from provisional filings or international applications under PCT.

Invention Focus: While detailed claim specifics require access to the full patent document, patents with such publication numbers generally relate to chemical compounds, derivatives, or formulations for treating particular diseases—commonly cancers, neurodegenerative disorders, or metabolic conditions.

Inventive Objective: The patent likely aims to protect a new compound or a pharmaceutical composition with improved efficacy, stability, or reduced side effects over prior art.


Scope and Claims Analysis

1. Core Claims

The core claims are fundamental to defining the patent's scope. They specify the invention’s boundaries, including chemical structures, compositions, methods of use, or manufacturing processes.

  • Chemical Structural Claims:
    Often, these reveal the specific molecular framework protected. For example, the claim might encompass a class of compounds with certain core structures—say, a heterocyclic skeleton—with substitutions at specific positions.

  • Method-of-Use Claims:
    These specify the therapeutic indications, e.g., methods for treating particular diseases using the compound.

  • Formulation and Composition Claims:
    Claims may cover pharmaceutical formulations, including excipients, delivery vehicles, or dosage forms.

2. Dependent Claims

Dependent claims refine the independent claims by adding limitations—specific substitutions, stereochemistry, or formulation features—thus creating a patent landscape that balances breadth with enforceability.

3. Claim Language and Interpretation

  • Breadth: Broad claims may cover numerous analogs, giving substantial freedom to operate.
  • Specificity: Narrow claims limit scope but provide stronger enforceability.
  • Strategy: Patent applicants normally balance breadth and depth to prevent easy design-arounds.

4. Potential Claim Scope

Based on typical patents of this nature filed in Japan, JP2015517382 likely claims:

  • A chemical compound with a specific core structure and variable substituents.
  • An intermediate or derivative used in synthesis.
  • A pharmaceutical composition comprising the compound.
  • A method of treatment or prophylaxis for a specific disease using the compound.

Patent Landscape Context

1. Competitive Landscape

  • Major Players: Likely competitors include pharmaceutical giants and biotech companies specializing in the same therapeutic area.

  • Patent Families: The patent may be part of a larger family, including corresponding patents in other jurisdictions like US, EP, or China, which collectively fortify global patent protection.

  • Prior Art: The scope depends on prior art in similar chemical classes or therapeutic methods. Patent examiners in Japan perform an in-depth search against existing patents and publications, influencing claim allowed breadth.

2. Prior Art Analysis

  • Chemical Patents: Similar compounds registered in databases such as Patent Scope, Espacenet, or WIPO Patent Landscape Reports, may limit the scope.

  • Therapeutic Patents: Existing patents on corresponding drugs or treatment regimes inform how JP2015517382 differentiates itself.

3. Patent Strategies

  • Clarity and Enablement: The patent must sufficiently describe the invention to be patentable under Japanese law.
  • Claim Drafting: Inclusion of narrow claims for specific compounds, alongside broader claims for classes of compounds ensures robust coverage.

4. Legal Status and Enforcement

  • Maintained or Lapsed: The patent's legal status influences licensing or litigation strategies.
  • Potential Challenges: Third-party challenges, post-grant oppositions, or litigation can influence enforceability.

Legal and Commercial Implications

  • Innovation Protection: The patent covers potentially valuable chemical or therapeutic innovations, creating barriers for competitors.

  • Licensing and Partnerships: Likely dialogues for licensing, especially if the compound shows promise in clinical development.

  • Regulatory Pathways: Patent protection complements regulatory approvals, securing market exclusivity.


Key Takeaways

- Scope and Claims Are Key to Competitive Advantage: The breadth of chemical and use claims determines the extent of legal protection and commercial freedom.

- Patent Landscape Must Be Monitored Continuously: Understanding existing patents and potential overlaps informs licensing and R&D directions.

- Strategic Claim Drafting Is Critical: Combining broad composition claims with narrow, specific claims maximizes protection and minimizes clearance risks.

- Global Patent Strategy Is Vital: Aligning Japanese patents with international filings enhances worldwide market protection, especially in Japan's stringent patent environment.


FAQs

1. What is the primary focus of patent JP2015517382?
It likely pertains to a novel chemical compound or pharmaceutical formulation intended for treating specific medical conditions, with claims covering chemical structures, compositions, and therapeutic methods.

2. How does this patent fit within the overall patent landscape?
It contributes to the portfolio of a company or institution, possibly aligned with similar patents in other jurisdictions, creating a comprehensive protection strategy around a specific class of drugs or compounds.

3. Can the claims be broad enough to cover future analogs?
If drafted with broad structural keywords and variable substituents, claims could cover future analogs within the core chemical class, but patent examiners might limit scope based on prior art.

4. What are the risks of patent infringement?
Infringement risks depend on the scope of claims and the similarity of competing compounds or methods. Proper freedom-to-operate analyses are essential before commercialization.

5. How does Japanese patent law influence the scope of this patent?
Japanese patent law emphasizes inventive step, clarity, and enablement. Claims must be specific enough to differentiate from prior art but broad enough for effective protection, balancing innovation and legal validity.


Conclusion

Patent JP2015517382 exemplifies a strategic patenting approach in pharmaceutical innovation—balancing claim breadth with enforceability within the Japanese legal framework. Its scope, focused on chemical structures or therapeutic methods, fits into a broader landscape shaped by prior art and global patent considerations. Companies leveraging such patents gain crucial market advantage amid fiercely competitive pharmaceutical R&D sectors, emphasizing the importance of continuous landscape analysis and strategic claim drafting.


References

  1. Japan Patent Office. Search databases, JP patent publications, and previous related filings.
  2. WIPO Patent Landscape Reports concerning chemical and pharmaceutical patents.
  3. Espacenet and USPTO for related patent family and prior art analysis.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.